Lifemed and EXL to Transform Healthcare Revenue Cycle Management into Revenue Cycle Automation

Rhea-AI Summary

EXL (NASDAQ:EXLS) and Lifemed announced a collaboration to apply AI-powered automation to healthcare revenue cycle management. Their adaptive platform uses a provider's own historical medical, contractual, and financial data in real time to identify errors, automate compliance checks, optimize billing codes, and manage denials and appeals.

The partners report this solution can deliver 10–25% higher net revenue, cut accounts receivable days by 30%+, and reduce related staffing workload by over 80%, helping providers accelerate reimbursements and focus staff on complex, high-risk cases.

Positive

• AI solution targets 10–25% higher net revenue for providers
• Accounts receivable days projected to decline by 30% or more
• Staffing workload in revenue cycle reduced by over 80%
• Real-time use of provider-specific medical, contractual, and financial data
• Automation of denials, appeals, and compliance checks before claim submission

Negative

• None.

News Market Reaction – EXLS

+0.81%

+0.81% Session close to close

In the Jun 9 session, EXLS gained 0.81%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights EXLS’s push to extend its AI and analytics capabilities into healthcare...

Analysis

This announcement highlights EXLS’s push to extend its AI and analytics capabilities into healthcare revenue cycle automation. The Lifemed partnership aims for 10–25% higher net revenue, at least 30% fewer AR days, and over 80% workload reduction. In context with recent AI integrations, awards, and leadership hires, it reinforces a data‑driven strategy. Investors may watch for concrete adoption metrics from the risk‑free 90‑day pilot and any financial disclosure tying these deployments to revenue growth or margin trends.

Key Figures

Net revenue uplift: 10–25% higher net revenue AR days reduction: 30% or more reduction in AR days Staff workload cut: Over 80% reduction in related staffing workload +1 more

4 metrics

Net revenue uplift 10–25% higher net revenue Expected impact from EXL–Lifemed RCM automation solution

AR days reduction 30% or more reduction in AR days Projected improvement in accounts receivables cycle

Staff workload cut Over 80% reduction in related staffing workload Automation impact on revenue cycle staffing

Pilot duration 90-day pilot Risk-free assessment period for the new solution

Historical Context

5 past events · Latest: Jun 04 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jun 04	AI integration deal	Positive	-0.2%	Integrated NVIDIA transaction model workflow into EXLerate.ai for financial institutions.
May 22	Magazine coverage	Positive	-1.9%	BetterInvesting profiled EXLS as a fundamentally attractive, potentially undervalued study case.
May 14	Industry leadership award	Positive	-0.8%	Named Leader in Everest Group Healthcare Payer Intelligent Operations PEAK Matrix.
May 12	Executive appointment	Positive	-1.5%	Appointed Bhupender Singh to drive international growth markets across EMEA and APAC.
May 07	Cybersecurity award	Positive	+1.2%	Won 2026 CSO Award for EXL SARA, its AI-powered security review platform.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent EXLS news has been consistently positive around AI, awards and leadership, yet four of the last five announcements saw negative next‑day moves, suggesting a pattern where constructive headlines often met with selling or profit‑taking. Only one award-related cybersecurity item aligned with a positive price reaction, implying investors may be cautious or using strength on good news to reduce exposure.

Recent Company History

Over the last few months, EXLS has highlighted multiple AI-driven initiatives and third‑party validations. On Apr 28, it reported strong Q1 2026 earnings and raised full‑year guidance. Subsequent filings showed major institutional holders and insider equity grants. Recent news included leadership changes, AI‑based security recognition, and integration with NVIDIA’s transaction model workflow. Today’s Lifemed collaboration fits this ongoing push to apply AI and analytics across verticals, extending that strategy into healthcare revenue cycle automation.

Key Terms

revenue cycle management, deep learning, neural network, pre-adjudication, +1 more

5 terms

revenue cycle management financial

"to disrupt and advance modern revenue cycle management (RCM) through AI-powered automation"

Revenue cycle management is the set of processes a healthcare provider or medical business uses to turn patient care into cash, including registering patients, billing insurers, submitting claims, collecting payments and handling denials. Think of it as the organization’s checkout system and follow-up team; efficient management shortens the time to get paid, reduces lost revenue and lowers financial risk, which directly affects cash flow and profitability that investors watch closely.

deep learning technical

"their AI capabilities use deep learning to analyze a provider's unique historical data"

Deep learning is a type of artificial intelligence that uses multiple layers of computer models to recognize patterns and make decisions from large amounts of data, similar to how someone improves at a task by practicing many examples. Investors care because companies that harness deep learning can automate work, improve products, cut costs or create new revenue streams — but adoption also involves investment, data and regulatory risks that can influence profits and valuation.

neural network technical

"aided by our Deepclaim neural network AI real-time pre-adjudication capabilities"

A neural network is a computer model that learns to recognize patterns from data by adjusting many simple processing units, similar to how a crowd of people each offers a small opinion that together forms a decision. Investors care because these models can power faster products, automate decisions, cut costs, and create new services — all of which can boost growth or create risks around accuracy, regulation, and competitive advantage.

pre-adjudication technical

"Deepclaim neural network AI real-time pre-adjudication capabilities"

Pre-adjudication is the preliminary review of a claim, invoice, or regulatory filing to check accuracy, eligibility and completeness before a final decision is made. For investors, it matters because it controls how quickly revenue or liabilities are recognized and highlights operational risk—like a quality check that can speed payment or reveal problems that could delay cash flow and require additional reserves.

accounts receivables financial

"cutting accounts receivables (AR) days by 30% or more"

Money a company expects to receive from customers who bought goods or services on credit; it's like the IOUs on a business's books when a customer runs a tab. It matters to investors because healthy, timely collections show real cash coming in to pay bills and support growth, while rapidly rising or long-overdue receivables can signal weak customer payments, hidden bad debt, or future cash shortfalls that hurt profits and valuation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MIAMI, June 8, 2026 /PRNewswire/ -- Paying healthcare providers is far from straightforward. Frequent policy changes, complex contracts, and diverse payment methods make reimbursement a moving target. Traditional rules-based systems can't keep pace with today's data volume or easily adapt to evolving requirements, leaving many organizations stuck with manual fixes, delays, rising administrative costs, and shrinking margins as denials continue to increase across the industry.

To address these challenges, EXL is collaborating with Lifemed to disrupt and advance modern revenue cycle management (RCM) through AI-powered automation. Instead of relying on generic industry datasets, their AI capabilities use deep learning to analyze a provider's unique historical data. This adaptive solution processes medical, contractual, and financial data in real time, transforming RCM from a reactive process into a proactive one by identifying errors, automating compliance checks, optimizing billing codes, and autonomously managing denials and appeals with minimal human intervention prior to submitting the claim to the payer. As a result, healthcare provider organizations can accelerate reimbursements, increase revenue, and free up staff to focus on complex, high-risk cases.

"At EXL, we're thrilled to collaborate with Lifemed to deliver a truly differentiated solution that redefines how providers handle their revenue cycle," said Trevor Jares, vice president of Integrated Revenue Management Solutions at EXL. "By integrating intelligence, automation, and real-time insights, we're driving a more efficient, next-generation approach to claims management – from submission through adjudication – we will be able to arm providers with a technology that will deliver a significant positive impact on their margins."

"Our collaboration with EXL represents a major leap in revenue cycle innovation," said Darian Rodriguez, executive vice president of Revenue Cycle Automation at Lifemed. "Together, we can accelerate the adoption of smarter, more efficient RCM workflows that shift operations from reactive error correction to proactive prevention aided by our Deepclaim neural network AI real-time pre-adjudication capabilities, helping providers recover more revenue, operate at maximum efficiency, and focus on delivering better care outcomes."

This solution boosts financial performance, decreases denials, and optimizes the revenue cycle, delivering 10–25% higher net revenue, cutting accounts receivables (AR) days by 30% or more and reducing related staffing workload by over 80%.

Contact us to discover how you can empower your data to achieve faster, more accurate payments with a risk-free assessment and 90-day pilot – now available and conducted live in your environment at no cost.

About Lifemed

Lifemed is a healthcare technology company redefining revenue cycle management through AI-powered automation. Its flagship platform, Deepclaim, leverages a proprietary deep learning neural network to analyze a provider's unique historical data in real time — automating compliance checks, optimizing billing codes, and autonomously managing denials and appeals before claims ever reach the payer. Unlike traditional rules-based systems, Deepclaim adapts continuously to evolving payer policies and contract complexity, transforming revenue cycle operations from reactive error correction to proactive prevention. Lifemed's solutions have delivered measurable outcomes for health systems nationwide, including significant improvements in net patient service revenue, reductions in AR days, and decreased administrative overhead. Learn more at lifemed.ai.

About EXL

EXL (NASDAQ: EXLS) is a global data and AI company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. EXL harnesses the power of data, AI, and deep industry knowledge to transform businesses, including the world's leading corporations in industries including insurance, healthcare, banking and capital markets, retail, communications and media, and energy and infrastructure, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have approximately 67,000 employees spanning six continents. For more information, visit www.exlservice.com.

View original content:https://www.prnewswire.com/news-releases/lifemed-and-exl-to-transform-healthcare-revenue-cycle-management-into-revenue-cycle-automation-302794391.html

SOURCE Life Med, Inc.

FAQ

What did EXL (NASDAQ:EXLS) and Lifemed announce on June 8, 2026?

EXL and Lifemed announced an AI-driven revenue cycle automation solution for healthcare providers. According to EXL, the platform analyzes provider-specific data in real time to streamline claims, reduce denials, and improve margins across the revenue cycle from submission through adjudication.

How can the EXL (EXLS) and Lifemed revenue cycle automation impact provider revenue?

The collaboration aims to increase healthcare providers’ net revenue by 10–25%. According to EXL, the AI-driven automation helps prevent errors, optimize billing codes, and manage denials and appeals proactively, which can recover more revenue from existing patient and payer activity.

How does the EXL (EXLS) and Lifemed solution affect accounts receivable days?

The joint solution is projected to cut accounts receivable (AR) days by 30% or more. According to EXL, faster, cleaner claims and proactive denial management support quicker reimbursements, which can ease administrative burdens for healthcare provider finance and billing teams.

What operational efficiencies does the EXL (EXLS) and Lifemed automation offer healthcare providers?

The platform is expected to reduce revenue cycle staffing workload by over 80%. According to EXL, automation of compliance checks, coding optimization, denials, and appeals lets staff shift focus toward complex, high-risk cases instead of routine, repetitive claim-processing tasks.

How does the EXL (EXLS) and Lifemed AI system differ from traditional RCM tools?

The system uses deep learning on each provider’s own historical data instead of generic datasets. According to EXL, it processes medical, contractual, and financial data in real time, enabling proactive error prevention and autonomous denial handling before claim submission to payers.

Is there a pilot program for the EXL (EXLS) and Lifemed revenue cycle automation?

Yes, a 90-day pilot is offered at no cost to providers. According to EXL, this risk-free assessment is conducted live in the provider’s environment to demonstrate faster, more accurate payments enabled by the AI-powered revenue cycle automation platform.